Purpose: Recurrent syncope leads to poor functional status and psychiatric impairment in patients with syncope. The aim of the study was to prospectively analyze the risk factors attributed to syncope recurrence. Materials and Methods: Between 2009 and 2010, 289 patients with all cause of syncope visited our institution. Syncope recurrences were followed for 1 year by telephone interview every 3 months. Results: We diagnosed 181 (63%) patients with neurally mediated syncope (NMS), 39 (13%) with orthostatic hypotension, 34 (12%) with cardiac syncope, and 35 (12%) with unexplained syncope. During the 1-year follow-up period, 19 (6.6%) patients suffered recurrent syncope. Kaplan-Meier curves showed that recurrent syncope was observed more often in patients with unexplained syncope compared with those with NMS (p < 0.01), and also observed more often in patients with six previous syncopal episodes compared to those with fewer episodes (p = 0.02). Cox regression analysis showed that the recurrence of syncope was significantly associated with more than six previous syncopal episodes (HR 5.38, 95% CI 1.17-24.71, p = 0.03) and that there was a tendency for association between recurrence of syncope and unexplained syncope (HR 6.13, 95% CI 0.96-39.1, p = 0.05). Conclusions: Patients with previous frequent syncopal episodes or unexplained syncope had higher rates of syncope recurrence during the follow up period.

Keywords:
Syncope, Recurrence
1.
Sarasin FP, Louis-Simonet M, Carballo D, Slama S, Rajeswaran A, Metzger JT, Lovis C, Unger PF, Junod AF: Prospective evaluation of patients with syncope: A population-based study. Am J Med 2001;111:177-184.
2.
Kapoor WN: Evaluation and outcome of patients with syncope. Medicine (Baltimore) 1990;69:160-175.
3.
Kapoor WN, Peterson J, Wieand HS, Karpf M: Diagnostic and prognostic implications of recurrences in patients with syncope. Am J Med 1987;83:700-708.
4.
Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Moya A, Raviele A, Sutton R, Theodorakis G, Wieling W: Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 2001;22:1256-1306.
5.
Baron-Esquivias G, Errazquin F, Pedrote A, Cayuela A, Gomez S, Aguilera A, Campos A, Fernandez M, Valle JI, Redondo M, Fernandez JM, Martinez A, Burgos J, Martinez-Rubio A: Long-term outcome of patients with vasovagal syncope. Am Heart J 2004;147:883-889.
6.
Linzer M, Pontinen M, Gold DT, Divine GW, Felder A, Brooks WB: Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol 1991;44:1037-1043.
7.
Ventura R, Maas R, Ruppel R, Stuhr U, Schuchert A, Meinertz T, Nienaber CA: Psychiatric conditions in patients with recurrent unexplained syncope. Europace 2001;3:311-316.
8.
Aydin MA, Maas R, Mortensen K, Steinig T, Klemm H, Risius T, Meinertz T, Willems S, Morillo CA, Ventura R: Predicting recurrence of vasovagal syncope: a simple risk score for the clinical routine. J Cardiovasc Electrophysiol 2009;20:416-421.
9.
Sumner GL, Rose MS, Koshman ML, Ritchie D, Sheldon RS: Recent history of vasovagal syncope in a young, referral-based population is a stronger predictor of recurrent syncope than lifetime syncope burden. J Cardiovasc Electrophysiol 2010;21:1375-1380.
10.
Romme JJ, van Dijk N, Go-Schon IK, Casteelen G, Wieling W, Reitsma JB: Association between psychological complaints and recurrence of vasovagal syncope. Clin Auton Res 2011;21:373-380.
11.
Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Ruiz Granell R, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W: Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631-2671.
12.
Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S: Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 1996;93:973-981.
13.
Krahn AD, Klein GJ, Yee R, Takle-Newhouse T, Norris C: Use of an extended monitoring strategy in patients with problematic syncope. Reveal investigators. Circulation 1999;99:406-410.
14.
Solano A, Menozzi C, Maggi R, Donateo P, Bottoni N, Lolli G, Tomasi C, Croci F, Oddone D, Puggioni E, Brignole M: Incidence, diagnostic yield and safety of the implantable loop-recorder to detect the mechanism of syncope in patients with and without structural heart disease. Eur Heart J 2004;25:1116-1119.
15.
Lombardi F, Calosso E, Mascioli G, Marangoni E, Donato A, Rossi S, Pala M, Foti F, Lunati M: Utility of implantable loop recorder (reveal plus) in the diagnosis of unexplained syncope. Europace 2005;7:19-24.
16.
Brignole M, Menozzi C, Maggi R, Solano A, Donateo P, Bottoni N, Lolli G, Quartieri F, Croci F, Oddone D, Puggioni E: The usage and diagnostic yield of the implantable loop-recorder in detection of the mechanism of syncope and in guiding effective antiarrhythmic therapy in older people. Europace 2005;7:273-279.
17.
Palmisano P, Accogli M, Zaccaria M, Luzzi G, Nacci F, Anaclerio M, Favale S: Predictive factors for pacemaker implantation in patients receiving an implantable loop recorder for syncope remained unexplained after an extensive cardiac and neurological workup. Int J Cardiol 2013;168:3450-3457.
18.
Kang GH, Oh JH, Chun WJ, Park YH, Song BG, Kim JS, On YK, Park SJ, Huh J: Usefulness of an implantable loop recorder in patients with syncope of an unknown cause. Yonsei Med J 2013;54:590-595.
19.
Paruchuri V, Adhaduk M, Garikipati NV, Steinberg JS, Mittal S: Clinical utility of a novel wireless implantable loop recorder in the evaluation of patients with unexplained syncope. Heart Rhythm 2011;8:858-863.
20.
van Dijk N, Quartieri F, Blanc JJ, Garcia-Civera R, Brignole M, Moya A, Wieling W: Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the physical counterpressure manoeuvres trial (pc-trial). J Am Coll Cardiol 2006;48:1652-1657.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.